Target intelligence / Profile preview

Stromal membrane-associated protein 1 (SMAP1)

Target
SMAP1
Molecular classification
GTPase-activating protein (specifically, ARF6 GTPase-activating protein), Accessory protein in membrane trafficking, Other
01

Overview

Stromal membrane-associated protein 1 (SMAP1) is a highly conserved intracellular protein that acts as a GTPase-activating protein (GAP) for ARF6, a member of the ADP-ribosylation factor family of small GTPases. SMAP1 regulates the formation and trafficking of clathrin-coated vesicles, processes essential for endocytosis, membrane recycling, and protein sorting between subcellular compartments including the trans-Golgi network. SMAP1 is also involved in the interaction between stromal and erythroid cells, contributing to the hematopoietic microenvironment, and is expressed in hematopoietic organs such as bone marrow. Its deficiency in animal models leads to abnormal receptor trafficking, enhanced transferrin endocytosis, impaired lysosomal sorting of c-KIT, and predisposition to hematological conditions reminiscent of myelodysplastic syndrome and acute myeloid leukemia. Chromosomal translocations involving SMAP1 have been linked with aplastic anemia and certain leukemias. In non-mammalian systems, SMAP1 homologs function in polarized membrane trafficking, further underscoring their role in directed protein sorting in multicellular organisms. Acting as both a regulator of membrane dynamics and a tumor suppressor, SMAP1 is crucial for normal cellular homeostasis and tissue function.

Other names
SMAP1SMAP-1FLJ13159stromal membrane-associated protein 1stromal membrane-associated GTPase-activating protein 1
02

Biological functions

Regulation of clathrin-dependent endocytosisIntracellular vesicle traffickingAssembly of clathrin coats on the trans-Golgi networkFormation of erythropoietic microenvironmentPolarized protein secretion in epithelial cells (notably in C. elegans and inferred for mammals)
03

Disease associations

Cancer (implicated as a tumor suppressor, with mutations in colorectal cancer and fusions in leukemia)Acute myeloid leukemia (as an MLL fusion partner)Myelodysplastic syndrome (MDS; disruption in mice causes MDS-like features)Severe aplastic anemia (translocation involving gene locus)Other
04

Safety considerations

Potential for oncogenesis if defective or mutated (involved in myelodysplastic syndrome, acute myeloid leukemia, colorectal cancer)Disruption may cause aberrant erythropoiesis and hematopoietic dysplasiaOther

Beyond the preview

Go deeper on Stromal membrane-associated protein 1 (SMAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stromal membrane-associated protein 1 (SMAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call